FDA Leaders Outline How AI Is Shaping The Agency's Work
The U.S. Food and Drug Administration is using generative artificial intelligence to help redact records before public release, summarize documents and evaluate scientific literature, federal officials said in a recent conference....To view the full article, register now.
Already a subscriber? Click here to view full article